RSS
TwitterFacebook

Tag Archives: AbbVie

Zinbryta Lawsuit

Amid reports of severe brain inflammation and deaths linked to side effects of Zinbryta, the multiple sclerosis drug was recalled globally in early March 2018. As a result of the drug makers failure to warn about the risk of encephalitis, meningoencephalitis and other problems, Zinbryta lawsuits are being evaluated by product liability lawyers. STATUS OF ZINBRYTA LAWSUITS: Lawyers are evaluating whether financial compensation may be available for individuals who have experienced any of the following complications following use of Zinbryta: Encephalitis Meningoencephalitis Other Sudden Brain Inflammation Wrongful Death >>SUBMIT INFO TO A ZINBRYTA LAWYER<< MANUFACTURERS: AbbVie, Inc. and Biogen, Inc.…